Penny Stock Screener
Option 1
Option 2
Option 3
Clear Filters
Penny Stocks
Market Cap
Price
Performance
Sector
Industry
Signals
SMA20
SMA50
SMA200
RSI14
After Hour Change
| Symbol | Name |
Price
(Pre-market |
Market Cap ▾ | Price Chart (1D) ▾ | % (1D) | % (1M) | % (6M) |
|---|---|---|---|---|---|---|---|
|
Clover Health Investments, Corp
|
4.48
|
2.38B |
|
-4.27% |
-1.75% |
+107.41% |
|
|
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
3.465
|
1.86B |
|
-16.71% |
+8.62% |
-3.75% |
|
|
Alvotech Ordinary Shares
|
5.00
|
1.78B |
|
-5.84% |
-1.96% |
+38.12% |
|
|
Nuvation Bio Inc.
|
4.45
|
1.56B |
|
-6.32% |
-23.01% |
-7.48% |
|
|
Cronos Group Inc. Common Share
|
3.21
|
1.18B |
|
+0.31% |
-2.43% |
+19.78% |
|
|
Taysha Gene Therapies, Inc. Common Stock
|
3.62
|
1.18B |
|
-2.95% |
-28.60% |
-39.16% |
|
|
Akso Health Group ADS
|
1.35
|
1.16B |
|
+0.00% |
+81.18% |
-36.62% |
|
|
GoodRx Holdings, Inc. Class A Common Stock
|
3.36
|
1.15B |
|
-4.14% |
-0.88% |
+42.98% |
|
|
Opko Health Inc.
|
1.53
|
1.14B |
|
-4.97% |
-4.97% |
+26.45% |
|
|
Mannkind Corporation
|
3.04
|
977.50M |
|
-4.70% |
-14.37% |
+10.55% |
|
|
Savara Inc.
|
4.45
|
914.30M |
|
-6.12% |
-13.26% |
-21.10% |
|
|
SL Science Holding Limited Ordinary Shares
|
1.53
|
857.96M |
|
-1.29% |
-15.47% |
+0.00% |
|
|
Arbutus Biopharma Corporation Common Stock
|
4.22
|
836.01M |
|
-1.63% |
-16.44% |
-9.83% |
|
|
Ardelyx, Inc.
|
3.09
|
797.80M |
|
-5.50% |
-8.85% |
-50.80% |
|
|
Geron Corp
|
1.17
|
751.69M |
|
-4.88% |
-9.30% |
-30.77% |
|
|
Inventiva S.A. American Depository Shares
|
2.94
|
694.53M |
|
-5.47% |
-22.43% |
-47.78% |
|
|
Sana Biotechnology, Inc. Common Stock
|
2.27
|
679.55M |
|
-8.28% |
-22.26% |
-34.58% |
|
|
Lexicon Pharmaceuticals, Inc.
|
1.52
|
676.33M |
|
-7.88% |
-24.75% |
-17.39% |
|
|
OmniAb, Inc. Common Stock
|
4.59
|
667.34M |
|
-2.96% |
+5.52% |
+194.23% |
|
|
MiMedx Group, Inc
|
4.43
|
646.49M |
|
-5.34% |
-6.34% |
+29.15% |
|
|
Annexon, Inc. Common Stock
|
3.41
|
646.46M |
|
-5.28% |
-13.23% |
-46.13% |
|
|
Prime Medicine, Inc. Common Stock
|
3.47
|
629.38M |
|
-3.88% |
+15.67% |
-5.45% |
|
|
Wave Life Sciences Ltd. Ordinary Shares
|
3.13
|
616.76M |
|
-1.88% |
-30.52% |
-57.24% |
|
|
Ironwood Pharmaceuticals, Inc. - Class A
|
3.50
|
578.34M |
|
-7.16% |
-16.07% |
-19.17% |
|
|
Pacific Biosciences of California, Inc.
|
1.73
|
537.74M |
|
-11.73% |
+29.10% |
+6.13% |
|
|
Evolent Health, Inc Class A Common Stock
|
4.57
|
516.68M |
|
-6.16% |
+22.19% |
+52.84% |
|
|
SS Innovations International Inc. Common Stock
|
2.53
|
507.24M |
|
-1.94% |
-22.63% |
-48.68% |
|
|
CytomX Therapeutics, Inc.
|
2.28
|
496.81M |
|
-5.39% |
-17.54% |
-53.37% |
|
|
Evotec SE American Depositary Shares
|
1.38
|
490.44M |
|
-2.82% |
-15.34% |
-57.14% |
|
|
Aclaris Therapeutics, Inc.
|
3.28
|
482.81M |
|
-6.02% |
-38.35% |
-17.59% |
|
|
Aquestive Therapeutics, Inc. Common Stock
|
3.78
|
474.43M |
|
-6.90% |
-21.58% |
-11.27% |
|
|
Entera Bio Ltd. Ordinary Shares
|
2.68
|
465.88M |
|
-3.25% |
-9.46% |
+123.33% |
|
|
Allogene Therapeutics, Inc. Common Stock
|
1.31
|
452.59M |
|
-2.24% |
-22.49% |
-44.73% |
|
|
Tilray Brands, Inc. Common Stock
|
3.04
|
449.27M |
|
-5.30% |
-22.65% |
-55.23% |
|
|
Cerus Corp
|
2.18
|
439.32M |
|
-3.54% |
-13.83% |
+9.00% |
|
|
Altimmune, Inc. Common Stock
|
2.20
|
427.94M |
|
-6.78% |
-32.10% |
-37.32% |
|
|
Autolus Therapeutics plc American Depositary Share
|
1.60
|
425.86M |
|
-6.98% |
-14.44% |
-0.62% |
|
|
Ovid Therapeutics Inc. Common Stock
|
2.15
|
419.89M |
|
-4.87% |
-19.78% |
-23.21% |
|
|
Community Health Systems, Inc.
|
2.88
|
406.11M |
|
-3.68% |
-3.36% |
-7.99% |
|
|
Strata Critical Medical, Inc. Class A Common Stock
|
4.54
|
401.64M |
|
+4.61% |
-13.03% |
+0.89% |
|
|
ARS Pharmaceuticals, Inc. Common Stock
|
4.02
|
399.78M |
|
-1.23% |
-3.48% |
-50.86% |
|
|
Myriad Genetics Inc
|
3.98
|
380.69M |
|
-8.51% |
+3.11% |
-20.40% |
|
|
Zura Bio Limited Class A Ordinary Shares
|
3.88
|
371.82M |
|
-9.35% |
-15.84% |
-32.05% |
|
|
Galectin Therapeutics Inc.
|
3.62
|
365.08M |
|
-2.43% |
-1.63% |
+60.18% |
|
|
Editas Medicine, Inc. Common Stock
|
2.35
|
360.91M |
|
-3.69% |
-13.28% |
-29.85% |
|
|
Indaptus Therapeutics, Inc. Common Stock
|
2.63
|
350.43M |
|
-7.72% |
-18.07% |
-13.49% |
|
|
Atea Pharmaceuticals, Inc. Common Stock
|
4.32
|
346.48M |
|
-4.64% |
-16.12% |
-24.21% |
|
|
Rezolute, Inc. Common Stock (NV)
|
3.58
|
346.27M |
|
-8.21% |
-10.05% |
+1.13% |
|
|
C4 Therapeutics, Inc.
|
2.765
|
340.16M |
|
-0.54% |
-19.86% |
-4.66% |
|
|
Relmada Therapeutics, Inc. Common Stock
|
3.10
|
330.68M |
|
-3.12% |
-26.54% |
-55.71% |
|
|
Opus Genetics, Inc. Common Stock
|
3.84
|
319.47M |
|
-5.19% |
-29.02% |
-33.22% |
|
|
Canopy Growth Corporation Common Shares
|
0.713
|
301.63M |
|
-3.06% |
-22.13% |
-38.00% |
|
|
Glass House Brands Inc.
|
3.19
|
300.63M |
|
-14.02% |
-60.27% |
+0.00% |
|
|
Fulcrum Therapeutics, Inc. Common Stock
|
3.65
|
278.79M |
|
-0.54% |
-3.69% |
-54.32% |
Top Stock Gainers
More ›
| 1. | JAGX Jaguar Health, Inc. | ▲ 53.59% |
| 2. | LHSW Lianhe Sowell International Group Ltd Class A Ordinary Shares | ▲ 46.66% |
| 3. | CTSO Cytosorbents Corp. | ▲ 34.31% |
Top Stock Losers
More ›
| 1. | RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | ▼ 16.71% |
| 2. | OMER Omeros Corporation | ▼ 13.78% |
| 3. | TLK PT Telekomunikasi Indonesia | ▼ 13.69% |
Top 100 popular stocks on Robinhood
More ›
| 1. | NVDA Nvidia Corp | ▼ 1.43% |
| 2. | AAPL Apple Inc. | ▲ 0.43% |
| 3. | GOOGL Alphabet Inc. Class A Common Stock | ▼ 2.47% |